Bio-Rad Laboratories, Inc.
BIO· NYSE
BIOBio-Rad Laboratories, Inc.
Filed Jul 29, 2022 · 10-Q · 29 days after period end · 0000012208-22-000046
| Metric | Q2 2022 | Q2 2021 | Q2 2020 | Q2 2019 |
|---|---|---|---|---|
| Revenue | $691.10M | $715.93M | $536.88M | $572.62M |
| Net Income | -$925.10M | $916.80M | $966.40M | $598.80M |
| EPS Diluted | -$31.05 | $30.41 | $32.15 | $19.86 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio-Rad Laboratories, Inc. · CIK 12208 · Engraved from SEC EDGAR
ended Jun 30, 2022 · filed Jul 29, 2022 · 29 d after period end
